ENGN – engene holdings inc. (US:NASDAQ)

News

enGene (ENGN) was downgraded by Wall Street Zen from "hold" to "sell"
enGene (ENGN) is now covered by WBB Securities. They set a "buy" rating and a $21.50 price target on the stock.
enGene (ENGN) had its "sell (d-)" rating reaffirmed by Weiss Ratings.
NewAmsterdam Pharma Company (NAMS): Huge Upside Potential Grabs Attention of Billionaire Stan Druckenmiller [Yahoo! Finance]
enGene Announces Name Change to enGene Therapeutics Inc.
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com